Neuro

Preliminary In Vitro Data on Anaconda Biomed’s Advanced Thrombectomy System Presented at ABC WIN 2019

BARCELONA, Spain–(BUSINESS WIRE)–Anaconda Biomed, a medical technology company developing next generation thrombectomy systems for the treatment of ischemic stroke, has announced that preliminary in vitro data on its Advanced Thrombectomy System were unveiled at the 39th ABC-WIN meeting in Val d’Isère, France. Presented by Dr. Tommy Andersson, Professor of Neurointervention, AZ Groeninge, Kortrijk, Belgium and […]

FDA Additionally Clears RAPID™ Imaging Platform for Use in Selecting Acute Stroke Patients for Clot Removal

MENLO PARK, Calif.–(BUSINESS WIRE)–iSchemaView, the worldwide leader in advanced imaging for stroke, today announced that the FDA has cleared the RAPID neuroimaging platform for use in selecting stroke patients who are likely to benefit from endovascular thrombectomy (clot removal). Specifically, this additional clearance means that RAPID CT-Perfusion and RAPID MR-Perfusion […]

Perflow Medical Expands IP Coverage for Novel Stream™ Dynamic Neuro-Thrombectomy Net Device and Cascade™ Non-Occlusive Remodeling Net

TEL AVIV, Israel, Jan. 10, 2019 /PRNewswire/ — Perflow Medical, an Israeli-based medtech company focused on next-generation neuro-interventional devices, today announced the issuance of four international patents that expand the global intellectual property (IP) coverage for the novel Stream™ Dynamic Neuro-Thrombectomy Net and Cascade™ Non-Occlusive Remodeling Net. Perflow’s growing global portfolio of eight issued […]

MRI Interventions Receives FDA Clearance for ClearPoint® PURSUIT™ Neuro Aspiration System

IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures involving deep-brain stimulation, ablation, and gene and drug delivery today announced FDA Clearance of the ClearPoint PURSUIT Neuro Aspiration system. The PURSUIT device was designed in collaboration […]

InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems

TEL AVIV, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced the publication of a meta-analysis of four clinical studies involving dual layered and […]

CERENOVUS LAUNCHES LARGEST GLOBAL REGISTRY TO STUDY STROKE-INDUCING BLOOD CLOTS REMOVED BY THROMBECTOMY

Company Also Receives European CE Mark Approval for Novel Stroke Technology Designed for Difficult to Extract Blood Clots IRVINE, Calif., Dec. 10, 2018 — Johnson & Johnson Medical Devices Companies* today announced that its CERENOVUS business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyze […]

InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard™ EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)

TEL AVIV, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced details from several presentations of updated CGuard™ EPS data at the recent VEITHsymposium […]

InspireMD Announces Regulatory and Reimbursement Approval of CGuard™ Embolic Prevention System in Australia

TEL AVIV, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that its novel CGuard™ Embolic Prevention System (EPS) has been granted regulatory approval […]

iSchemaView RAPID™ Integrates with Join, Allm’s Medical Communications Platform

MENLO PARK, Calif.–(BUSINESS WIRE)–iSchemaView, the worldwide leader in advanced imaging for stroke, today announced that the RAPID platform is now compatible with Join, a medical communication app developed by Allm, a multinational developer of mobile communications platforms for the healthcare industry. The integration of RAPID imaging results into the Join […]

InspireMD Announces Presentation of Preliminary Cumulative Three-Year CGuard™ EPS Safety and Efficacy Data at the Transcatheter Cardiovascular Therapeutics 2018 Conference

TEL AVIV, Israel, Sept. 27, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that preliminary cumulative three-year follow-up safety, efficacy and stroke prevention durability data from […]